Trial intelligence / Profile preview

3D-printed sildenafil tablets versus Revatio pharmacokinetic crossover study in healthy adults

NL-OMON49936Active, not recruiting

Sponsor
Leiden University Medical Center
Start
Dec 2021
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of sildenafil in pulmonary arterial hypertension (PAH), sponsored by Leiden University Medical Center. Started Dec 2021; status: active, not recruiting.

02

Drugs

sildenafil
03

Conditions

pulmonary arterial hypertension (PAH)

Beyond the preview

Go deeper on NL-OMON49936.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON49936.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call